Protagonist Therapeutics, Inc. (PTGX)

81.41 +1.16 (+1.45%) USD  |  NASDAQ  |  Jan 13, 16:00
81.41 0.00 (0.00%) After-Hours: 18:28
More

Protagonist Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
MannKind Corp. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade